IRIDEX Corporation

IRIX ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2026 FY2024 FY2023 FY2022 FY2021 FY2019 FY2018 FY2017
Operating Activities
Net Income $-4.4M $-8.9M $-9.6M $-7.5M $-6.3M $-8.8M $-12.8M $-12.9M
Depreciation & Amortization $523.0K $584.0K $1.1M $485.0K $504.0K $688.0K $809.0K $858.0K
Depreciation $200.0K $244.0K $277.0K $257.0K $488.0K $672.0K $793.0K $842.0K
Amortization $323.0K $333.0K $333.0K $228.0K $16.0K $16.0K $16.0K $16.0K
Stock-Based Compensation — — — — — — — —
Net Cash from Operating Activities $-2.1M $-7.3M $-6.7M $-9.5M $-3.2M $-7.9M $-10.0M $-3.6M
Investing Activities
Capital Expenditures $143.0K $13.0K $109.0K $286.0K $97.0K $128.0K $440.0K $575.0K
Business Acquisitions — — — $0 — — — —
Net Cash from Investing Activities $-143.0K $-13.0K $-109.0K $-286.0K $-93.0K $-509.0K $-827.0K $-782.0K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $6.0M $2.6M $-5.0K $-73.0K $2.5M $-156.0K $10.4M $2.3M
Net Change in Cash $3.6M $-4.6M $-6.9M $-9.9M $-1.0M $-8.5M $-513.0K $-2.0M
Free Cash Flow $-2.3M $-7.3M $-6.9M $-9.8M $-3.3M $-8.0M $-10.5M $-4.1M
← Newer Page 1 of 2 Older →